206 related articles for article (PubMed ID: 38775687)
1. Knowledge framework of intravenous immunoglobulin resistance in the field of Kawasaki disease: A bibliometric analysis (1997-2023).
Zhang J; Huang H; Xu L; Wang S; Gao Y; Zhuo W; Wang Y; Zheng Y; Tang X; Jiang J; Lv H
Immun Inflamm Dis; 2024 May; 12(5):e1277. PubMed ID: 38775687
[TBL] [Abstract][Full Text] [Related]
2. Bibliometric and visual analysis of Kawasaki disease in children from 2012 to 2022.
Cui Z; Luo F; Wang J; Diao J; Pan Y
Front Pediatr; 2023; 11():1142065. PubMed ID: 37576134
[TBL] [Abstract][Full Text] [Related]
3. A global bibliometric analysis on Kawasaki disease research over the last 5 years (2017-2021).
Tan W; Jing L; Wang Y; Li W
Front Public Health; 2022; 10():1075659. PubMed ID: 36703854
[TBL] [Abstract][Full Text] [Related]
4. A bibliometric analysis of Kawasaki disease from 1974 to 2022.
Xu L; Zhang J; Dong J; Chen Q; Ma S; Jiang J; Zheng Y; Zhuo W; Tang X; Gao Y; Li X; Yang F; You G; Lv H; Huang H
Heliyon; 2024 Mar; 10(5):e27290. PubMed ID: 38486756
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.
Peng C; Kuang L; Zhao J; Ross AE; Wang Z; Ciolino JB
J Control Release; 2022 May; 345():625-645. PubMed ID: 35321827
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
[TBL] [Abstract][Full Text] [Related]
7. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
[TBL] [Abstract][Full Text] [Related]
8. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[TBL] [Abstract][Full Text] [Related]
9. Knowledge mapping of prodromal Parkinson's disease: A bibliometric review and analysis (2000-2023).
Wang S; An N; Wang Y; Li Y; Li H; Bai Y
Medicine (Baltimore); 2024 Feb; 103(5):e36985. PubMed ID: 38306521
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C
Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036
[TBL] [Abstract][Full Text] [Related]
11. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
Han CL; Zhao SL
Med Sci Monit; 2018 Oct; 24():7264-7270. PubMed ID: 30307902
[TBL] [Abstract][Full Text] [Related]
13. Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.
Song B; Lin Z; Feng C; Zhao X; Teng W
Front Endocrinol (Lausanne); 2023; 14():1252389. PubMed ID: 37795362
[TBL] [Abstract][Full Text] [Related]
14. Knowledge domain and hotspots concerning photosensitive hydrogels for tissue engineering applications: A bibliometric and visualized analysis (1996-2022).
Fu H; Yu B; Wang H; Tong H; Jiang L; Zhang Y; Meng G; Sun M; Lin J
Front Bioeng Biotechnol; 2022; 10():1067111. PubMed ID: 36466359
[No Abstract] [Full Text] [Related]
15. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Tang B; Lo HH; Lei C; U KI; Hsiao WW; Guo X; Bai J; Wong VK; Law BY
Phytomedicine; 2020 Apr; 70():153208. PubMed ID: 32283413
[TBL] [Abstract][Full Text] [Related]
16. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
Zhang RL; Lo HH; Lei C; Ip N; Chen J; Law BY
Curr Opin Pharmacol; 2020 Oct; 54():72-81. PubMed ID: 32956895
[TBL] [Abstract][Full Text] [Related]
17. Knowledge domain, research hotspots and frontiers in physiology teaching reforms from 2012 to 2021: A bibliometric and knowledge-map analysis.
Xu J; Sun S; Zhao Y; Ma Q
Front Med (Lausanne); 2023; 10():1031713. PubMed ID: 37020677
[TBL] [Abstract][Full Text] [Related]
18. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
[TBL] [Abstract][Full Text] [Related]
19. Immune control in Kawasaki disease knowledge mapping: a bibliometric analysis.
Zhang L; Shi L; Zhang R; Lin X; Bao Y; Jiang F; Wu C; Wang J
Cardiol Young; 2024 Apr; ():1-16. PubMed ID: 38602085
[TBL] [Abstract][Full Text] [Related]
20. Advances in gut microbiome in metabonomics perspective: based on bibliometrics methods and visualization analysis.
Wang J; Dong P; Zheng S; Mai Y; Ding J; Pan P; Tang L; Wan Y; Liang H
Front Cell Infect Microbiol; 2023; 13():1196967. PubMed ID: 37325519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
